Facts
The Petitioner, Glaxo Group Limited (part of GlaxoSmithKline), sought the cancellation of Respondent No. 1’s registration for the trademark ‘PAXIL’ under Class 5
Source reference: p. 1-2The Petitioner established global use and registration of the mark since 1991
Source reference: p. 2Respondent No. 1 had acquired the mark from Rallis India (who registered it in 1973) and obtained a fresh registration in April 2005
Source reference: p. 13-14The Petitioner alleged that Respondent No. 1 had not used the mark for over 20 years since registration
Source reference: p. 3Respondent No. 1 admitted to non-use, justifying it as a commercial decision for "expansion of business" and challenged the Petitioner's status as a "person aggrieved"
Source reference: p. 8, 10Issues
1. Whether the Petitioner qualifies as a "person aggrieved" under Section 47 of the Trade Marks Act, 1999, despite having no commercial use of the mark in India.
Source reference: p. 4 / para. 30(E)2. Whether Respondent No. 1’s non-use of the mark is protected by the "special circumstances in the trade" exception under Section 47(3).
Source reference: p. 8 / para. 30(B)3. Whether the impugned registration is liable to be removed on grounds of non-use and "squatting."
Source reference: p. 7 / para. 30(D)Law Applied
The court applied Section 47 of the Trade Marks Act, 1999, which mandates the removal of a mark for non-use for a continuous period of five years
Source reference: p. 22It relied on Hardie Trading Ltd. v. Addisons Paint Chemicals Ltd., which defined "person aggrieved" liberally to include those whose legal rights are limited by the mark's presence
Source reference: p. 4-5The "special circumstances" exception under Section 47(3) was interpreted through Aktiebolaget Jonkoping Vulcan v. VSV Palanichamy, holding that such circumstances must be external, industry-wide, and not personal commercial decisions
Source reference: p. 9, 24The court also cited Neon Laboratories v. Medical Technologies regarding the legislative intent to prevent trademark hoarding/squatting
Source reference: p. 7Reasoning
The court found that the Petitioner is a "person aggrieved" because the impugned registration creates a practical barrier to the Petitioner registering its own globally recognized mark in India
Source reference: para. 30(E)-(F)The court rejected Respondent No. 1’s "territoriality" defense, noting that Section 47 does not require an applicant to prove Indian goodwill, only a genuine interest in the register's purity
Source reference: para. 30(G)Regarding non-use, the court held that Respondent No. 1’s justification—"expansion of business"—was a voluntary, internal commercial strategy and not a "special circumstance in the trade" (which requires external factors like import duty or war)
Source reference: para. 30(B)-(C)Consequently, the mark’s presence on the register for 20% years without use constituted "squatting," which violates the fundamental purpose of trademark law to serve as a source identifier
Source reference: para. 30(D)Holding
The court allowed the Petition, holding that Respondent No. 1 had no bona fide intention to use the mark and had failed to demonstrate special circumstances justifying 20 years of non-use
The court directed the removal of Respondent No. 1’s registration for ‘PAXIL’ (No. 1153709) from the Register of Trade Marks
Source reference: p. 28Original Court PDF
Glaxo Group LimitedvsShreya Life Sciences Private Limited
Click to open original judgment
Original judgment, available to read, download and summarize on LawLens.in